Literature DB >> 19900782

Endovascular treatment of traumatic thoracic aortic injuries: short- and medium-term Follow-up.

Valentín Fernandez1, Gaspar Mestres, Jordi Maeso, José Manuel Domínguez, M Carmen Aloy, Manel Matas.   

Abstract

BACKGROUND: Successful thoracic endovascular aortic repair (TEVAR) with low rates of complications has been referred to in the treatment of traumatic thoracic aortic injuries; however, we still do not know the long-term behavior. In this series, short- and intermediate-term results of TEVAR of traumatic aortic injuries are analyzed.
METHODS: The clinical charts and courses of 20 patients (mean age, 31.8 years; age range, 15-65 years; 14 [70%] men) with traumatic thoracic aortic injuries treated with TEVAR were retrospectively reviewed. Mean delay from trauma to intervention was 15 days (range, 0-180 days).
RESULTS: The initial success rate was 100%, with no deaths or intraoperative leaks, although in 4 (20%) patients, injuries were repaired in the arterial access site. The mean postoperative follow-up was 43.53 months (range, 5.5-108.0 months). Four (20%) patients required reintervention: 2 postoperative revascularizations of the left subclavian artery (20% of the patients in whom the ostium was intentionally occluded) and 2 aortic reinterventions (endovascular treatment of a collapsed stent graft and open repair after thrombosis of another stent graft). All reinterventions were successfully performed and no additional complications were registered during follow-up. Asymptomatic findings related to the stent graft included lack of proximal device-wall apposition in 8 patients (40%), intragraft mural thrombus formation during the first 6 months in 7 patients (35%), and an asymptomatic fracture of the longitudinal reinforcing bar of the stent graft 4 years later in 1 patient (5%).
CONCLUSION: Although not completely exempt of complications, TEVAR provides a reliable method for the treatment of traumatic thoracic aortic injuries with good results in the short- and medium-term follow-up. All complications have been treated successfully. Long-term evolution of lack of proximal device-wall apposition and intragraft mural thrombus formation should be closely monitored to prevent long-term complications. Copyright 2006 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19900782     DOI: 10.1016/j.avsg.2009.05.013

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  6 in total

1.  Endovascular stent grafts in urgent blunt and penetrating thoracic aortic trauma.

Authors:  Kenneth J Kolbeck; John A Kaufman
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

2.  Failed surgical ligation of the proximal left subclavian artery during hybrid thoracic endovascular aortic repair successfully managed by percutaneous plug or coil occlusion: a report of 3 cases.

Authors:  Geert Maleux; Johan Vaninbroukx; Sam Heye
Journal:  J Cardiothorac Surg       Date:  2011-04-08       Impact factor: 1.637

3.  A hybrid therapy as a third approach for type 1 proximal endoleak of thoracic endovascular aortic replacement: Caroticocarotid bypass and re-redo endovascular therapy.

Authors:  Cem Arıtürk; Murat Okten; Sinan Dağdelen; Fevzi Toraman; Hasan Karabulut
Journal:  J Saudi Heart Assoc       Date:  2013-10

4.  Thrombosis of a descending thoracic aortic endovascular stent graft in a patient with factor V Leiden: case report.

Authors:  Ganesh S Kumpati; Amit N Patel; David A Bull
Journal:  J Cardiothorac Surg       Date:  2014-03-11       Impact factor: 1.637

5.  Intragraft Obstructive Thrombus Two Years After Endovascular Repair of Traumatic Aortic Injury: A Case Report and Review of the Literature.

Authors:  E Beijer; V P W Scholtes; M Truijers; J H Nederhoed; K K Yeung; J D Blankensteijn
Journal:  EJVES Vasc Forum       Date:  2021-11-09

6.  Late Stent Thrombosis in a Patient with Endovascular Aortic Repair for Blunt Thoracic Aortic Injury.

Authors:  Michael H Chiu; Youri Kaitoukov; Amanda Roze des Ordons
Journal:  Case Rep Vasc Med       Date:  2022-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.